abstract |
The present invention discloses a biaryl urea RORγt inhibitor, and specifically relates to a biaryl urea derivative, as represented by formula I, with an RORγt inhibiting activity, and a manufacturing method thereof, and a pharmaceutical composition comprising the compound. Further disclosed is an application of the compound for treating an RORγt-related disease. |